VERONICA WOODFORD: Open Payments
NPI 1720335441 · BEL AIR, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$470 in 18 payments from 9 companies in 2025. Trend: 2023 $92 · 2024 $772 · 2025 $470
Food & beverage: $391Education: $79
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 5 | $160 |
| Sage Therapeutics, LLC | 2 | $69 |
| Sumitomo Pharma America, Inc. | 2 | $54 |
| Evofem Biosciences, Inc. | 2 | $42 |
| CooperSurgical, Inc. | 2 | $38 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $37 |
| Organon LLC | 1 | $27 |
| ABBVIE INC. | 1 | $27 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $16 |
Products named: Veozah, ZURZUVAE, GEMTESA, Phexxi, Paragard T 380A, Mirena, NEXPLANON, BOTOX.
Industry payments across MD — which companies pay providers there.
